Related Experiment Video
Updated: Aug 4, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
Published on: September 19, 2013
Downregulation of PTEN/MMAC/TEP1 expression in human prostate cancer cell line DU145 by growth stimuli
Dhundy R Bastola1, Gurcharan S Pahwa, Ming-Fong Lin
1Department of Biochemistry and Molecular Biology, College of Medicine, University of Nebraska Medical Center, Omaha 68198-4525, USA.
Abstract:
Genetic alterations and/or deletion of the tumor suppressor gene PTEN/MMAC/TEP1 occur in many types of human cancer including prostate cancer. We describe the production of monoclonal antibody against recombinant human PTEN and the study of PTEN gene and protein expression in three commercially available human prostate cancer cell lines, PC-3, LNCaP, and DU 145. Northern blotting analyses showed that LNCaP and DU145 but not PC-3 cells expressed PTEN mRNA. However, Western blotting analyses using a monoclonal antibody against PTEN demonstrated the expression of PTEN protein in DU145 but not LNCaP cells. In DU 145 cells, PTEN expression at both the mRNA and protein levels inversely correlated with serum concentrations and levels of PKB/Akt phosphorylation. In addition, the basal activity of PKB/Akt as indicated by level of phosphorylation was higher in prostate cancer cells which do not express PTEN than that in the cells expressing wild type PTEN. Thus, PTEN may play a critical role in regulating cellular signaling in prostate cancer cells.
Insights
The tumor suppressor gene PTEN is crucial in prostate cancer. This study developed an antibody to detect PTEN, finding its expression impacts cell signaling pathways like PKB/Akt.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- PTEN (Phosphatase and tensin homolog) is a tumor suppressor gene frequently altered in human cancers, including prostate cancer.
- Understanding PTEN expression is vital for elucidating prostate cancer development and progression.
Purpose of the Study:
- To develop a monoclonal antibody for detecting human PTEN.
- To investigate PTEN gene and protein expression in human prostate cancer cell lines.
- To explore the relationship between PTEN expression and cellular signaling pathways.
Main Methods:
- Production of a monoclonal antibody against recombinant human PTEN.
- Northern blotting to analyze PTEN mRNA expression in PC-3, LNCaP, and DU 145 cell lines.
- Western blotting using the developed antibody to detect PTEN protein expression.
- Analysis of PKB/Akt phosphorylation levels in relation to PTEN expression.
Main Results:
- PTEN mRNA was detected in LNCaP and DU 145 cells, but not in PC-3 cells.
- PTEN protein was expressed in DU 145 cells but not in LNCaP cells.
- In DU 145 cells, PTEN expression inversely correlated with serum concentration and PKB/Akt phosphorylation.
- Prostate cancer cells lacking PTEN exhibited higher basal PKB/Akt activity compared to those expressing wild-type PTEN.
Conclusions:
- PTEN plays a significant role in regulating cellular signaling pathways within prostate cancer cells.
- The developed monoclonal antibody is a valuable tool for studying PTEN expression.
- Differential PTEN expression contributes to varying cellular signaling activities in prostate cancer.
More Related Videos
Related Concept Videos
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway

